| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 31 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SAGE | Sage Therapeutics, Inc. | 31 Jul 2025 | 1 | $0 | 4 | Director | 31 Jul 2025, 12:03 |
| SAGE | Sage Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:13 |
| SAGE | Sage Therapeutics, Inc. | 10 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 16:57 |
| SAGE | Sage Therapeutics, Inc. | 03 Jan 2024 | 1 | $0 | 4 | Director | 04 Jan 2024, 16:07 |
| SAGE | Sage Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 16:07 |
| SAGE | Sage Therapeutics, Inc. | 16 Mar 2023 | 1 | $0 | 4 | Director | 17 Mar 2023, 16:09 |
| SAGE | Sage Therapeutics, Inc. | 15 Mar 2023 | 0 | $0 | 3 | Director | 17 Mar 2023, 16:10 |